prev. next
Cold Spring Harbor Laboratory

Please visit the Tansey Lab home page


Regulation of transcription by the ubiquitin-proteasomesystem. Evidence from a number of laboratories,including our own, suggests that components of the ubiquitin-proteasome system directly regulate transcription: (i) transcriptional activators can becontrolled positively and negatively by ubiquitin modification (ubiquitin; green sphere), (ii) RNA polymerase II (RNA pol II) ubiquitylation is important for transcription-coupled DNA repair,(iii) histone ubiquitylation signals the transcriptionalstatus of chromatin, (iv) ubiquitin-ligases can function as transcriptional coactivators, and (v) components of the proteasome are important for transcriptional elongation and chromatin modification.
William Tansey
Professor
Ph.D., University of Sydney, 1991
Oncogene regulation; transcription; protein destruction

email tansey@cshl.edu, phone (516) 367-8436, fax (516) 367-8874

Transcription and ubiquitin-mediated proteolysis are two processes that might seem to have little in common. Transcription is the first step in the life of any protein; proteolysis the last. Despite the disparate nature of these processes, a growing body of evidence suggests that components of the ubiquitin–proteasome system are intimately involved in the regulation of gene expression. Research in our laboratory is geared toward understanding how these two processes intersect, and the consequences of this intersection for cellular growth control.

Our current research is divided into two areas. One area is focused on revealing the basic mechanisms that connect the transcription and ubiquitin systems. We have previously found that the destruction of transcription factors is intimately tied to their ability to activate transcription, and that components of the proteasome play an essential role in the regulation of histone modifications. We are currently studying how prototypical transcription factors, such as the yeast activator Gal4, interact with ubiquitin and with the proteasome to regulate gene expression.

Our second area of research is focused on understanding how the destruction of transcription factors impacts mammalian cell growth control. These studies center on Myc, an oncoprotein transcription factor that features prominently in human cancer. We have previously found that Myc is rapidly destroyed by the ubiquitin-system, and that oncogenic mutations within Myc stabilize the protein, allowing it to accumulate. We seek to identify the cellular machinery that targets Myc for ubiquitin-mediated destruction, and learn how the regulation of Myc turnover—and loss of control of this process—relates to human cancer.


Please visit the Tansey Lab home page.

Selected Publications

Lee, D., Ezhkova, E., Li, B., Pattenden, S.G., Tansey, W.P., and Workman, J.L. 2005. The proteasome regulatory particle alters the SAGA coactivator to ehance its interactions with transcriptional coactivators. Cell 123: 423–436.

Muratani, M., Kung, C., Shokat, K.M., and Tansey, W.P. 2005. The F-box protein Dsg1/Mdm30 is a transcriptional co-activator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell 120: 887899.

Herbst, A., Hemann, M.T., Tworkowski, K.A., Salghetti, S.E., Lowe, S.W., and Tansey, W.P. 2005. A conserved element in Myc that negatively regulates its pro-apoptotic activity. EMBO Rep. 6: 177183.

Ezhkova, E., and Tansey, W.P. 2004. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol. Cell 13: 435–442.

Kim, S.-Y., Herbst, A., Twokowski, K.A., Salghetti, S.E., and Tansey, W.P. 2003. Skp2 regulates Myc protein stability and activity. Mol. Cell 11: 11771188.








Cold Spring Harbor Laboratory